Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India

Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment

(2017) Anuradha Chowdhary et al.   JOURNAL OF INFECTIOUS DISEASES

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Azole Drug Import into the Pathogenic Fungus Aspergillus fumigatus

(2015) Brooke D. Esquivel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nationwide Surveillance of Azole Resistance in Aspergillus Diseases

(2015) Edith Vermeulen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus

(2015) R. A. Paul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

(2015) Paul E. Verweij et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of chronic fungal rhinosinusitis in rural India

(2015) Arunaloke Chakrabarti et al.   MYCOSES

Evaluation of mRNA Expression Levels of cyp51A and mdr1, Candidate Genes for Voriconazole Resistance in Aspergillus flavus

(2015) Azam Fattahi et al.   Jundishapur Journal of Microbiology

Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus

(2015) W. S. Moye-Rowley   Frontiers in Microbiology

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia

(2015) Anuradha Chowdhary et al.   Frontiers in Microbiology

Whole-Genome Comparison of Aspergillus fumigatus Strains Serially Isolated from Patients with Aspergillosis

(2014) D. Hagiwara et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer

(2014) B. C. Monk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The clinical spectrum of pulmonary aspergillosis

(2014) C. Kosmidis et al.   THORAX

Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)

(2013) A. Alastruey-Izquierdo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroAntifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus SectionFlavi

(2013) Sarah S. Gonçalves et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus

(2013) S. Krishnan Natesan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The T788G Mutation in thecyp51CGene Confers Voriconazole Resistance in Aspergillus flavus Causing Aspergillosis

(2012) Wei Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to Voriconazole Due to a G448S Substitution in Aspergillus fumigatus in a Patient with Cerebral Aspergillosis

(2012) T. Pelaez et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

(2012) Eveline Snelders et al.   PLoS One

Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing

(2012) Simone M. T. Camps et al.   PLoS One

CAVER 3.0: A Tool for the Analysis of Transport Pathways in Dynamic Protein Structures

(2012) Eva Chovancova et al.   PLoS Computational Biology

Toward almost closed genomes with GapFiller

(2012) Marten Boetzer et al.   GENOME BIOLOGY

In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs

(2011) M. R. Shivaprakash et al.   MYCOSES

Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling

(2010) E. Snelders et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-  Demethylase (CYP51) Isoenzymes A and B

(2010) A. G. S. Warrilow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Scaffolding pre-assembled contigs using SSPACE

(2010) Marten Boetzer et al.   BIOINFORMATICS

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

(2010) A. McKenna et al.   GENOME RESEARCH

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

(2010) A. Espinel-Ingroff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

(2009) J. W. Baddley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Velvet: Algorithms for de novo short read assembly using de Bruijn graphs

(2008) D. R. Zerbino et al.   GENOME RESEARCH

Molecular characterisation of cyp51A and cyp51B genes coding for P450 14α-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus

(2008) Suganthini Krishnan-Natesan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Differences in pathogenicity and clinical syndromes due toAspergillus fumigatusandAspergillus flavus

(2008) Alessandro C. Pasqualotto   MEDICAL MYCOLOGY